Literature DB >> 2057537

Acute and chronic effects of the atypical antidepressant, mianserin on brain noradrenergic neurons.

A L Curtis1, R J Valentino.   

Abstract

Corticotropin-releasing factor (CRF), which may serve as a neurotransmitter in the noradrenergic nucleus, locus coeruleus (LC), has been postulated to be hypersecreted in depression. The present study was designed to test the hypothesis that antidepressants interfere with CRF putative neurotransmission in the LC. The acute and chronic effects of the atypical antidepressant mianserin on LC spontaneous discharge, LC sensory-evoked discharge, LC activation by a stressor which requires endogenous CRF, and LC activation by ICV CRF were characterized in halothane-anesthetized rats. Acute IV administration of mianserin (0.0001-1.0 mg/kg) increased LC spontaneous discharge and decreased LC discharge evoked by repeated sciatic nerve stimulation in a dose-dependent manner. Additionally, mianserin (0.1 mg/kg) inhibited LC activation by hemodynamic stress (IV infusion of nitroprusside) and by ICV administration of CRF (3.0 micrograms). In rats chronically administered mianserin LC spontaneous and sensory-evoked discharge rates, and LC activation by CRF were similar to those of untreated rats or rats chronically administered saline. Moreover, acute IV administration of mianserin (0.1 mg/kg) to rats chronically treated with mianserin was less effective in altering LC spontaneous and sensory-evoked discharge. In contrast, LC activation by hemodynamic stress was still greatly attenuated in rats chronically administered mianserin. This is similar to the previously reported effect produced by chronic administration of the antidepressant, desmethylimipramine. The present results demonstrate that acute administration of low doses of mianserin attenuates LC activation by a variety of stimuli and suggest that tolerance develops with chronic administration to some of the effects of mianserin on LC discharge characteristics.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2057537     DOI: 10.1007/bf02244286

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists.

Authors:  K Rasmussen; G K Aghajanian
Journal:  Brain Res       Date:  1986-10-22       Impact factor: 3.252

Review 2.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

Review 3.  Norepinephrine in depressive reactions. A review.

Authors:  W E Bunney; J M Davis
Journal:  Arch Gen Psychiatry       Date:  1965-12

4.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

5.  Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus.

Authors:  R J Valentino; S L Foote; G Aston-Jones
Journal:  Brain Res       Date:  1983-07-04       Impact factor: 3.252

6.  Serotonin receptor sensitivity after acute and chronic treatment with mianserin.

Authors:  M A Blackshear; E Sanders-Bush
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

7.  Distribution of corticotropin-releasing-factor-like immunoreactivity in brainstem of two monkey species (Saimiri sciureus and Macaca fascicularis): an immunohistochemical study.

Authors:  S L Foote; C I Cha
Journal:  J Comp Neurol       Date:  1988-10-08       Impact factor: 3.215

8.  Corticotropin-releasing factor disrupts sensory responses of brain noradrenergic neurons.

Authors:  R J Valentino; S L Foote
Journal:  Neuroendocrinology       Date:  1987-01       Impact factor: 4.914

9.  Corticotropin and cortisol response to human CRH as a probe for HPA system integrity in major depressive disorder.

Authors:  K P Lesch; G Laux; H M Schulte; H Pfüller; H Beckmann
Journal:  Psychiatry Res       Date:  1988-04       Impact factor: 3.222

10.  Hemorrhage-induced secretion of corticotropin-releasing factor-like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids.

Authors:  P M Plotsky; W Vale
Journal:  Endocrinology       Date:  1984-01       Impact factor: 4.736

View more
  3 in total

1.  The effect of sympathetic antagonists on the antidepressant action of alprazolam.

Authors:  Ra Al-Tubuly; Sm Aburawi; Ea Alghzewi; Zm Gorash; S Errwami
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

2.  Antidepressant drugs with differing pharmacological actions decrease activity of locus coeruleus neurons.

Authors:  Charles H K West; James C Ritchie; Katherine A Boss-Williams; Jay M Weiss
Journal:  Int J Neuropsychopharmacol       Date:  2008-10-27       Impact factor: 5.176

Review 3.  Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.

Authors:  H Lehnert; C Schulz; K Dieterich
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.